Position in BSX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$411,776
-$182,341 QoQ
Shares Held
9,648
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#913
of 1,468 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BankPlus Trust Department holds $2,819,457 across 7 Medical Devices names. BSX ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
12,075 | $1,092,304 | |
| 2 | ABT |
Abbott Laboratories
|
7,551 | $685,177 | |
| 3 | SYK |
Stryker Corp
|
1,703 | $536,172 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
9,648 | $411,776 | |
| 5 | PODD |
Insulet Corp
|
470 | $71,557 | |
| 6 | MDT |
Medtronic plc
|
164 | $12,829 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
112 | $9,642 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $411,776 | 9,648 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $594,117 | 9,468 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $939,578 | 9,854 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $956,383 | 9,796 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,092,467 | 10,171 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $846,887 | 8,395 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $735,818 | 8,238 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||